A. Atli results 4
· Newest (Page 1/1, per page 25)
Author: A. Atli ×Clear All Filters
Search Results
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processingNARA Subscribed
Rationale Therapeutic administration of psychedelics has shown significant potential in historical accounts and recent clinical trials in the treatment of depression and other mood disorders. A recent randomized double-blind phase-IIb study demonstrated the safety and efficacy of COMP360, COMPASS Pathways’ proprietary synthetic formulation of psilocybin, in participants with treatment-resistant depression. Objective While the...
Previous1Next